Travere Therapeutics, Inc. TVTX License and collaboration revenue — Cost of goods sold

Similar metrics at other companies

LULUProduct costs — Cost of goods sold

$746.45M+14.3%

ENSProduct — Cost of goods sold

$612.85M+2.0%

ENSService — Cost of goods sold

$83.14M+19.8%

WShipping and Fulfillment — Cost of goods sold

$500M+5.3%

COCOShipping and Handling — Cost of goods sold

$4.36M+33.0%

VFCShipping and Handling — Cost of goods sold

$127.98M+7.9%

FAQ

What is Travere Therapeutics, Inc.'s license and collaboration revenue — cost of goods sold?

Travere Therapeutics, Inc. (TVTX) reported license and collaboration revenue — cost of goods sold of $0 in Q1 2026.

How has Travere Therapeutics, Inc.'s license and collaboration revenue — cost of goods sold changed year-over-year?

Travere Therapeutics, Inc.'s license and collaboration revenue — cost of goods sold decreased by 100.0% year-over-year, from $3.43M to $0.

What does license and collaboration revenue — cost of goods sold mean?

This metric captures the direct costs incurred to fulfill obligations associated with licensing and collaboration agreements, such as manufacturing support or technical transfer expenses. Monitoring these costs relative to segment revenue helps assess the profitability and operational efficiency of the company's partnership-based business model. Lower costs relative to revenue indicate higher margins on collaborative activities.